product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Goat anti Diphtheria Toxin
catalog :
3710-0956
quantity :
1 ml
price :
339 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
application :
ELISA
more info or order :
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
ProductCode :
3710-0956
Description :
Goat anti Diphtheria Toxin
Specificity :
Diphtheria Toxin
TargetSpecies :
Bacterial
Host :
Goat
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
E
ApplicationTypes :
ELISA
Quantity :
1 ml
Quantity Value :
1
Quantity Type :
ml
Uniprot Accessions :
Q6NK15
Entity Formats :
HRP,Purified
UNSPSC :
41116161
Concentration :
IgG concentration 5.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
239
PriceEUR :
339
PriceUSD :
339 USD
PriceCHF :
369
PriceSEK :
3695
PriceNOK :
3713
PriceDKK :
2527
NotForSaleInCountries :
AU
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.